Ellin Md Berman MD
Professor of Medicine, Cornell University-Weill Medical College
Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Berman
Dr. Ellin Berman is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Harvard Medical School and has been in practice 40 years. Dr. Berman accepts several types of health insurance, listed below. She is one of 72 doctors at Memorial Sloan Kettering Cancer Center and one of 7 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Hematology. She has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1980 - 1983
Boston University Medical CenterResidency, Internal Medicine, 1977 - 1980
Harvard Medical SchoolClass of 1977
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2024 - 2027
NY State Medical License 1982 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Most Compassionate Doctor American Registry
Clinical Trials
- Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia Start of enrollment: 2002 Apr 01
- Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Start of enrollment: 2003 Dec 01
- Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors Start of enrollment: 2006 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Histopathologic and Clinical Characteristics of Cutaneous Toxicities of Tyrosine Kinase Inhibitors: Insights Into Pathologic Mechanisms From a Retrospective Cohort.Ian Nykaza, Tania Platero-Portillo, Ellin Berman, Mark B Geyer, Jae H Park
The American Journal of Dermatopathology. 2025-12-01 - Two decades of single-institution data reveal rare long-term survivors of relapsed/refractory Burkitt lymphoma.Rabeya Molla, Kurt Bantilan, Ellin Berman, Philip Caron, Lorenzo Falchi
Haematologica. 2025-08-07 - 1 citationsA niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.Ioanna Mosialou, Abdullah M Ali, Rossella Labella, Brygida Bisikirska, Alvaro Cuesta-Dominguez
Cancer Cell. 2025-06-09
Abstracts/Posters
- Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response PathwaysEllin Berman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral TrialCl...Ellin Berman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Pregnancy Considerations for Patients with Chronic Myeloid LeukemiaApril 28th, 2023
An Interview with Associate Professor Stavroula Kousteni (Part One)August 8th, 2016
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
